Abstract:Objective To evaluate the diagnostic efficacy of MRI diffusion kurtosis imaging (DKI) and quantitative dynamic contrast enhancement MRI (DCE-MRI) in benign and malignant breast lesions, and to explore the differential diagnosis ability for different pathological types and molecular subtype lesions. Methods Sixty four females were retrospectively enrolled in the study of MRI diffusion kurtosis imaging and quantitative dynamic contrast enhancement between November 20 and May 2017. All of them were confirmed to have benign or malignant lesions after surgical resection or puncture. All patients underwent axial T1WI, DKI and DCE-MRI examinations. The mean kurtosis (MK) and mean diffusivity (MD) values were calculated by the DKI model, and the hemodynamic parameters were obtained by quantitative dynamic contrast enhancement, including volume transfer constant (Ktrans), rate constant (Kep), extravascular extracellular space distribute volume per unit tissue volume (Ve) and blood volume fraction (Vp). Pathological analysis was performed to monitor the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER-2) and nuclear proliferation index Ki67. The breast cancer was divided into Luminal A type, Luminal B type, HER-2 positive and triple-negative 4 subtypes. The differences of DKI parameters and DCE-MRI parameters between benign and malignant breast lesions were compared using two independent samples t test (normal distribution and homogeneity of variance) or Mann-Whitney U test (skewed distribution or variance). ROC analysis was used to evaluate the value of DKI and DCE-MRI parameters in differential diagnosis of benign and malignant breast lesions with pathological results as the gold standard. The Mann-Whitney U test and Kruskal-Wallis H test were used to compare the differences of DKI and DCE-MRI parameters among different prognostic factors and molecular subtypes of breast cancer. Spearman rank correlation analysis was used to evaluate the correlation between DKI and DCE-MRI parameters and different prognostic factors. Results Sixty-four cases were single lesions, with breast cancer in 23 cases and 41 cases of benign lesions. In breast cancer, there were 9 cases of Luminal A type, 7 cases of Luminal B type, 3 cases of HER-2 positive type and 4 cases of triple negative type. The positive numbers of ER, PR and HER-2 were 14, 11 and 10 cases respectively. Nineteen cases showed high expression of Ki67, while 4 cases showed low expression. There were significant differences in MK, MD, Ktrans and Kep between benign and malignant lesions (P<0.05). However, there was no significant difference between Ve and Vp (P>0.05). The area under the ROC for the differential diagnosis of benign and malignant breast lesions were 0.897, 0.808, 0.844 and 0.842, respectively. The combined multi-parameter differential diagnosis improved the efficacy. Combined with the above four parameters, the area under the ROC was 0.950. The diagnosis Sensitivity, specificity and accuracy were 0.870, 0.951 and 0.922 respectively. The Ktrans and Vp values of patients with ER positive and ER negative, as well as Ve value of deferent lymph node status, were significantly different (P<0.05), but there was no significant difference between the other prognostic factors (P>0.05). There was a moderate positive correlation between ER and Ktrans and Vp values. There was a low positive correlation between lymph node status and Ve value (r= 0.6, 0.5 and 0.4, respectively, P<0.05). No correlation was found among other parameters and prognostic factors (P>0.05). There were no significant differences in DKI and DCE-MRI parameters among different subtypes of breast cancer patients (all P>0.05). Conclusion DKI combined with DCE-MRI can improve the differential diagnosis of breast lesions and some DCE-MRI parameters are related to prognostic factors.

Value of a dedicated breast MRI(DBMRI) on diagnosis of breast intraductal papillomas

MRI and the Pathology of Breast Invasive Micropapillary Carcinoma

The role of magnetic resonance imaging in detection and surgical treatment of breast intraductal papillomas

Evaluation of intraductal papillary mucinous neoplasms of the pancreas on MDCT and MRI]

Diagnostic Evaluations of Ultrasound and Magnetic Resonance Imaging in Mammary Duct Ectasia and Breast Cancer

A Study of a Breast MRI Abbreviated Protocol for Breast Neoplasm Screening

Comparision of magnetic resonance imaging and ultrasound in diagnosis of breast intraductal papilloma

The Value of Automated Breast Volume Scanning, Combined with Virtual Touch Tissue Imaging Quantification in the Differential Diagnosis of Benign and Malignant Breast Lesion

Mri Characteristics of Intraductal Papilloma

Value of MRI in Assessing the Invasiveness of Intraductal Papillary Neoplasms of the Bile Duct

MR Imaging Evalution of Ductal Carcinoma in Situ and Ductal Carcinoma in Situ with Small Invasive Foci of Breast

The value of high-field-strength MRCP in diagnosing intraductal papillary mucinous neoplasms of pancreas

MRI Diagnosis of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Magnetic resonance imaging features for differentiating breast papilloma with high-risk or malignant lesions from benign papilloma: a retrospective study on 158 patients

[Value of Magnetic Resonance Imaging in Diagnosing Breast Lesions Which Need Biopsy].

Diagnostic Value of Diffusion Kurtosis Imaging Combined with Quantitative Dynamic Contrast-Enhanced MRI in Breast Lesions

The value of MRI for downgrading of breast suspicious lesions detected on ultrasound

MRI characteristics of breast ductal carcinoma in situ

A retrospective observational study of intraductal breast papilloma and its coexisting lesions: A real‐world experience

Comparison of high frequency ultrasonography vs. molybdenum target X-ray in diagnosis of breast intraductal papilloma

Diffusion-weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm